Meperia, a leading provider of healthcare procurement intelligence and strategic sourcing solutions, announced that it has received a strategic growth investment from Diversis Capital, a technology-focused private equity firm with $3 billion in assets under management.
The investment will enable Meperia to expand its operations across the United States, the United Kingdom, and Ireland while accelerating the development of its AI-powered analytics and predictive capabilities. The goal is to transform how hospitals and health systems manage procurement decisions, product data, and supply chain intelligence.
Major healthcare organizations, including Northside Hospital, Valleywise Health, and Allegheny Health Network, currently utilize Meperia’s platform. The company provides solutions that normalize product data, optimize sourcing decisions, and deliver real-time market intelligence to help hospitals reduce costs, improve contract management, and maintain data integrity.
The new partnership with Diversis Capital comes at a time when hospitals are grappling with fragmented product data, inconsistent pricing information, and manual sourcing processes that often result in millions of dollars in unnecessary spending. Meperia’s data-driven solutions aim to address these systemic inefficiencies by enabling greater visibility and control across procurement workflows.
Through this investment, Meperia will enhance several key platform modules. These include The Library, which uses AI-enabled content management to create universal product information; the Virtual Item Master (VIM), a catalog of millions of fully attributed and normalized products; the Content Manager for centralized data normalization; and the Implant Management Solution, which automates “Bill Only” and “Bill & Replace” processes. Additional modules, such as Contract Management, Market Intelligence, and FDA Recall Integration, will also see expanded AI and analytics capabilities to enhance pricing data accuracy and prevent the purchase of recalled products.
Diversis Capital’s investment will further strengthen Meperia’s capacity to scale its predictive intelligence and bring next-generation procurement insights to healthcare providers worldwide. The company’s AI-driven approach to sourcing and supply chain management continues to redefine how hospitals achieve cost transparency and operational efficiency in a complex, data-fragmented environment.
KEY QUOTES:
“This partnership with Diversis Capital marks a transformative milestone. Healthcare organizations face mounting challenges with fragmented product data and opaque pricing that cost millions annually. With Diversis’s operational expertise and growth capital, we’re accelerating our ability to deliver data normalization and procurement intelligence to hospitals globally.”
Tom Frith, President, Meperia
“Clean data is the bedrock of a modern supply chain. By normalizing and attributing every item, we created the visibility needed to manage spend, reduce risk, and stay proactive—not reactive.”
Pam Pulit, Director, Supply Chain System & Master Data Management, Allegheny Health Network
“Meperia has built the procurement intelligence platform that solves healthcare’s long-standing purchasing challenges. They’ve proven that clean data and AI-driven insights can transform hospital purchasing decisions. We’re investing to scale this critical capability globally.”
Ron Nayot, Managing Partner, Diversis Capital
